Skip to main content
Be The Investor
Home›Stocks›AKRO
AKRO

Akero Therapeutics, Inc.

AKRO
NASDAQUnited States flagUSReal-Time Price
$54.65USD
0.00 (0.00%)Today
BTI Score

BASIC required or higher

View pricing
BTI Fair Market Cap
$1.11B
+306.73% vs fair
Biotechnology
High Risk

Akero Therapeutics, Inc. (AKRO) Forecast & Price Targets

Review available Akero Therapeutics, Inc. (AKRO) analyst price targets and compare them with earnings and valuation. Analyst targets are separate from BTI scores; missing data is marked unavailable.

AKRO stock forecast and analyst price targets

Analyst price targets estimate possible future share prices. They are separate from BTI scores and fair-value models. The highest and lowest targets describe the provider's range, not the probability of a bull or bear scenario.

AKRO targets — Financial Modeling Prep — price-target-consensus. Target publication dates and investment horizons are not supplied by this feed.
MeasureTarget (USD)Difference from available quote
Highest analyst target56.00+2.5%
Consensus analyst target48.40-11.4%
Lowest analyst target38.00-30.5%

The comparison uses the available quote, which may be delayed. It is not an expected return over a specified period.

How should I evaluate the AKRO forecast?

Compare the targets with reported earnings, cash flow, valuation assumptions and company risks. A price target alone does not determine whether an investment is suitable.